Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic efficacy and PK-PD of intranasal sufentanil, ketamine, and CT001 after mandibular third molar extraction
2021-003258-21Phase 2Completed
- Sponsor
- Cessatech
- Start
- Nov 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in postoperative pain comparing Intranasal CT001, Intranasal sufentanil and Intranasal ketamine (3 arms). Primary endpoints: Postoperative analgesic efficacy and Pharmacokinetic-pharmacodynamic relationship. Started Nov 2021; status: completed.
02
Drugs
CT001sufentanilketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2021-003258-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003258-21.